No, 600mg daily of oral progesterone will not kill you
A daily oral dose of 600 mg of progesterone is not lethal. This dose has been studied in clinical trials and used in clinical practice without reports of mortality, though it may cause significant side effects.
Evidence from Clinical Use
The FDA-approved labeling for oral micronized progesterone indicates standard dosing ranges from 200-400 mg daily for various indications 1. While 600 mg exceeds typical therapeutic doses, clinical research has evaluated this dose:
A 2023 multicenter randomized trial specifically studied oral micronized progesterone at 600 mg/day in 440 women undergoing IVF cycles 2. The study reported no deaths or life-threatening adverse events at this dose, though it was associated with lower pregnancy rates compared to lower doses.
The FDA drug label describes overdosage management as symptomatic treatment, with no specific mention of lethal doses 1. This suggests progesterone lacks acute life-threatening toxicity even at supratherapeutic doses.
Expected Side Effects at High Doses
At 600 mg daily, you should expect significant sedative and neurological effects rather than life-threatening complications:
- Extreme drowsiness and sedation - progesterone metabolites have anesthetic properties 3
- Dizziness and difficulty with motor coordination - may prevent safe operation of vehicles or machinery 1
- Potential for hypnotic states - one case report documented a hypnotic state lasting approximately 2 hours after 400 mg 3
- Blurred vision, difficulty speaking, difficulty walking, and feeling abnormal 1
The FDA label specifically warns that these neurological symptoms warrant immediate discussion with a healthcare provider 1.
Mechanism of Safety
Oral progesterone undergoes extensive first-pass hepatic metabolism (>90%), which limits systemic bioavailability but produces high levels of metabolites 4. These metabolites cause the sedative effects but do not appear to cause organ failure or death at doses up to 600 mg daily.
Important Caveats
While not lethal, 600 mg daily:
- Significantly exceeds FDA-approved dosing for all indications (maximum approved is 400 mg for secondary amenorrhea) 1
- May increase thrombotic risk - though data on progestin-only formulations show minimal venous thromboembolism risk at contraceptive doses 5, higher doses have not been adequately studied for this outcome
- Should not be taken during pregnancy - FDA Category B, but not indicated for use in pregnancy 1
- Requires caution with driving or operating machinery due to profound sedation 1
The primary danger at 600 mg daily is not death, but rather incapacitation from sedation and the risk of accidents due to impaired consciousness and motor function. If someone is taking this dose, they should be advised to take it at bedtime while standing with water 1, avoid driving or operating machinery, and have close medical supervision.